Purpose: In this work we have developed a novel method of dose distribution comparison, the inverse gamma (IG) evaluation, by modifying the commonly used gamma evaluation method.
comparison method being used clinically, although several alternative methods have been proposed [7] [8] [9] [10] [11] [12] .
Derived from the dose difference (ΔD) test and the distance-toagreement (Δd) test 10 , the gamma index method calculates the difference between two dose grids in a combined spatial-dose domain 6 .
The result of the gamma test can be summarized by a single percentage value, usually referred to as the "pass rate" or "gamma agreement index" (GAI), which describes the percentage of points in the two dose distributions that agree within specified ΔD and Δd (producing a gamma value less than or equal to 1.0). Gamma evaluation results can also be plotted as a two-dimensional gamma distribution with desired spatial resolution, as well as histograms, so that the locations of regions of disagreement can be identified and investigated 6 . The gamma evaluation method has the advantage of producing a quantitative measure based on both dose and spatial criteria, so that large dose differences occurring in high-dose-gradient regions do not disproportionately affect the results of the comparison. The gamma evaluation method has, however, been criticized for being less clinically intuitive than more conventional dose-comparison methods 8 , being sensitive to dose grid resolution 13 and having poor sensitivity and specificity to clinical dosimetric inaccuracies (when evaluated in terms of global dose difference) [14] [15] [16] [17] [18] [19] [20] .
Several alternative dose comparison methods have been proposed, to avoid some of the perceived weaknesses of the gamma index method [7] [8] [9] [10] [11] [12] . Specifically, several algorithms have been proposed which attempt to account for the differing levels of biological relevance associated with comparison results in different regions of the dose distribution. For example, the normalized agreement test (NAT) 7 , maximum allowed dose difference (MADD) method 8 28, 29 ), given the widespread adoption and acceptance of the gamma evaluation method.
This study investigates a modified gamma evaluation method, the "inverse gamma" (IG) evaluation, which calculates the gamma evaluation criteria (ΔD or Δd) that would be needed to achieve a predefined GAI. Li et al. 30 proposed a similar approach where the passing percentage is fixed and combination of ΔD and Δd was calculated; however, has not been implemented into clinical QA. It is expected that the modified IG method proposed in this study will provide additional information for clinical PSQA, to augment standard gamma evaluation results by providing users with an indication of the minimum Δd for which a specified GAI can be achieved, when (for example) the ΔD is set to 3%.
| MATERIALS AND METHODS

2.A | Standard gamma index method
The gamma index at a point r r is defined as 6 :
where 2) where δ(r e , r r ) is the dose difference between evaluated and reference doses at point r, ΔD is the dose difference criterion, r(r e , r r ) is the spatial distance between evaluated and reference dose points, and Δd is the distance-to-agreement criterion. The GAI is calculated as the percentage of points for which eq. (2) results in a gamma value less than or equal to 1.0, indicating agreement within the specified ΔD and Δd. The gamma index method implemented in this study used the global gamma normalization where the ΔD is normalized to the global maximum dose.
2.B | Inverse gamma with fixed ΔD (IG ΔD )
IG ΔD calculates the minimum distance-to-agreement criterion (Δd) that is needed to achieve a specified GAI, given a fixed value of the dose difference criterion (ΔD). The fixed ΔD used in this study was selected to be 3%, denoted as IG ΔD = 3% . The IG algorithm performs iterative global gamma calculations with Δd increasing from 0 mm in 0.1 mm increments, until the specified GAI is reached and the required minimum Δd is reported. The resulting Δd can be denoted as Δd GAI = 100% or 95%, ΔD = 3% . Clinically this value would then be used to compare against a tolerance. The time required to perform the IG calculations is dependent on the number of iterations required. Lower Δd values require less time to calculate than higher Δd values. On average it takes a few minutes to run on a desktop PC, which is practical in clinical settings.
As an example, the ΔD was fixed at 3% in this work and the values of Δd required to achieve GAI values of 95% and 100% were investigated, for a pre-existing set of VMAT PSQA results. The ΔD of 3% was chosen for this work because it is very widely recommended and used. Recent surveys 31, 32 suggested that 3%/3 mm are currently the most commonly used gamma evaluation criteria, and the AAPM's task group report on IMRT commissioning (TG-119) 28 used 3%/3 mm and the AAPM's more recent task group report on modulated radiotherapy quality assurance (TG-218) 29 
2.C | Application
In-house gamma evaluation code was developed using Python v 3.5.2, following the method proposed by Low et al. 
| RESULTS
The mean and standard deviation (SD) of IG ΔD = 3% (when GAI was set to 100% and 95%), compared with their original gamma values, of the 53 VMAT arcs were calculated and displayed in Table 1 . The detailed values for each individual arc were displayed in Table A1 in the Appendix. and 95%. Regions of high and low geometric uncertainties can be easily identified, which is not easily achievable by performing multiple gamma evaluation with varying Δd criteria. Figure 2 illustrates the results of the IG analysis of the VMAT PSQA results, showing the Δd required to achieve the specified GAI values for each of the 53 arcs, when the ΔD is fixed at 3%. The mean Δd required to achieve a GAI of 100% was 4.5 ± 3.1 mm. The number of arcs that achieved a GAI of 100% only when Δd was 10 mm or more provides a graphic indication of the clinical unsuitability of requiring that all points pass the gamma evaluation. The mean Δd required to achieve the more-conventional GAI of 95% was 0.7 ± 0.5 mm, with the majority arcs (75.5%) requiring Δd less than 1 mm.
Examination of the results in Fig. 2 indicates that if initial PSQA testing of these arcs had used gamma evaluation criteria of 3%/ 2 mm, all arcs would have achieved a GAI greater than 95%. Data in Fig. 2 also indicate that that if initial PSQA testing of these arcs had used gamma evaluation criteria of 3%/1 mm, then 75.5% of the arcs would have achieved a GAI greater than 95%.
The highest Δd calculated is from arc 2 using GAI of 100%, which indicated that a Δd of nearly 17 mm is needed for all points to pass gamma when the ΔD value is set to 3%. However, when GAI of 95% is used, Δd has been significantly dropped to only 1.6 mm. This behavior will be discussed in the next section. 
| DISCUSSION
VMAT Arcs
Gamma pass rate (%) 2%, 2 mm, 5% LDT Δd GAI = 100%,
ΔD = 3% (mm)
Δd GAI = 95%,
Mean ± SD 97.9 ± 1. TG-218 also states that the Δd should be a function of the clinical necessity of placing steep dose gradients, yet discovering the locations of the dose gradient errors in the patient is difficult with the commonly used IMRT QA methods 29 . The IG method proposed in this study will tackle this difficulty by searching for a single Δd for the structures that provides a pass without running multiple gamma evaluations for each structure. This method also allows a simple check of the value against a tolerance table.
This IG method has been proposed as a means to provide additional information, to augment standard gamma evaluation results during PSQA testing of individual treatment plans. For example, if the local PSQA action threshold is a GAI of 95%, and a given treatment plan achieves a GAI of 94%, using criteria of 3%/2 mm, instead of iteratively changing the Δd criterion by manual trial and error, the proposed IG ΔD = 3% method can be used as an additional test of verification more efficiently. This method can be used to identify the minimum Δd for which a GAI of 95% is achievable for that plan. The two-dimensional Δd distribution map can also identify the region of high and low Δd values. In cases where it is concerned that there are points having deviations larger than the selected gamma criteria, however, are not able to be identified due to using GAI of 95%, the GAI of 100% can be used to eradicate this common weakness of the conventional gamma evaluation method. It is worth mentioning that the weakness of using GAI of 100% is that it is very sensitive to noise. In cases where there are problems with even a single pixel (noise, dead pixel, etc), the IG method could potentially keep doing iterations until reaching the maximum specified gamma criterion, which is both time consuming and giving less meaningful results (for example arc 2). Therefore, care needs to be taken when using GAI of 100%. The GAI values of near 100%, for example 99%, 99.5%, are highly recommended in order to avoid the disturbance of random noise in the dataset.
Similarly, the IG method may be used to retrospectively audit cohorts of PSQA results (producing results similar to Fig. 2) , so that the suitability of existing or proposed gamma evaluation criteria and action thresholds can be evaluated. The data produced by applying IG analysis to aggregated PSQA results may be evaluated using statistical process control (SPC) methods, such as those have been used to identify uncontrolled behaviors in linac and tomotherapy quality assurance results [42] [43] [44] [45] .
The 3% ΔD criterion was selected in this study because it is widely used, in combination with a range of Δd values 28, 29, 31, 33, [35] [36] [37] [38] [39] [40] , but the use of 3% as a ΔD criterion is not universal 26, 34 . Similarly, GAI values of 100% and 95% were selected as examples of extreme and commonly-used PSQA action levels, respectively. The IG method can, however, be used with any other ΔD or GAI values, to fit the needs of individual centres.
The IG method also offers more variability and flexibility than simply fixing the ΔD criterion. The algorithm is amenable to using a fixed Δd to identify the ΔD that would produce a specified GAI.
Alternatively, the ratio of ΔD to Δd can be fixed, enabling the IG F I G . 1. Global gamma distribution map (left). IG ΔD = 3% (GAI = 100%) Δd distribution map (middle). IG ΔD = 3% (GAI = 95%) Δd distribution map (right).
. DTA values (Δd) required to achieve GAI values of 95% (darker/orange plot symbols) and 100% (lighter/blue plot symbols), with a set ΔD of 3%.
algorithm to identify the pair of criteria (related to each other via a set ratio) that produce a specified GAI. (Examples of the use of these two additional forms of the IG index are provided in the appendix.).
For centres that are committed to using the standard gamma evaluation method for PSQA, the IG indices developed in this study could be used to investigate or justify the choice of gamma criteria for ongoing PSQA use, based on combination of the local treatment technique and measuring device.
| CONCLUSIONS
A novel dose comparison method called the inverse gamma (IG) method has been developed. The IG ΔD = 3% index has been tested on 25 retrospective VMAT PSQA plans (53 arcs). This index was proven useful to quantify the minimum Δd based on given ΔD of 3% in order to pass a given GAI. This method has the potential to be implemented clinically to perform additional analysis of failed plans and to provide those who prescribe, plan and test modulated radiotherapy treatments with more detailed dosimetric information about the reliability with which planned doses can be delivered. The IG method also has the potential to be used in retrospective internal and inter-departmental audits, to evaluate the suitability of the local gamma evaluation criteria.
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APPEN DIX
The body of this manuscript describes the IG method, using the example of keeping the ΔD fixed and identifying the minimum Δd required to achieve a specified GAI for each PSQA comparison (abbreviated to IG ΔD ). Two additional forms of the IG algorithm have been investigated: inverse gamma with fixed Δd (IG Δd ) and inverse gamma with fixed dose-distance-ratio (IG ΔD/Δd ).
As an obvious analogue to IG ΔD , IG Δd keeps the Δd fixed and calculates the minimum ΔD required to achieve a specified GAI for each PSQA comparison. The algorithm performs iterative global gamma calculations of ΔD from 0% with 0.1% increment until the minimum ΔD were found to achieve a GAI that is no less than the predefined threshold GAI value. To provide an indication of the results achievable using IG Δd , the 53 VMAT PSQA results used in this work were re-evaluated using a fixed Δd of 1 mm, denoted as IG Δd = 1mm (see Fig. A1 ). A comparable example of the resulting ΔD distribution when applying the IG Δd = 1mm method is illustrated in The IG ΔD/Δd concept is based on the gamma index definition (global normalization). The difference is that instead of calculating GAI based on fixed ΔD and Δd in the gamma method, IG ΔD/Δd calculates the minimum ΔD and Δd based on fixed GAI and dose-difference ratio (ΔD/Δd). The dose-difference ratio used in this study was unity (e.g., 3%, 3 mm, 2%/2 mm, 1%/1 mm, etc), denoted as IG ΔD/Δd = 1.0 . While keeping a constant ratio of 1, the algorithm performs iterative global gamma calculations of GAI using ΔD and Δd ranging T A B L E A 1 Results of IG ΔD/Δd = 1.0 , IG Δd = 1mm and IG ΔD = 3% calculated for 53 VMAT arcs using 100% GAI and 95% GAI respectively. | 199 from 1%/ 1 mm with 0.1%/mm increment until the resulting GAI equals to or above the predefined threshold GAI value (see Fig. A1 ). Figure A1 shows how the IG results can vary, depending on the selection of the GAI and on which specific IG method (fixed ΔD, fixed Δd or fixed ΔD/Δd) is used for the comparison. Clearly, the ΔD
and Δd values required to achieve a "passing" result are higher when the GAI action threshold is 100%, compared to when the GAI action threshold is 95%. Similarly, the ΔD values required to exceed the GAI action threshold are higher when the Δd is set to 1 mm, than when the Δd is allowed to vary at a constant ratio with the ΔD. Figure A1 also provides an indication of how the indices developed in this study can be used to evaluate locally used or proposed gamma criteria and GAI, as part of a statistical process control (SPC)
process. In Fig. A1 , the mean ΔD and Δd criteria that result from an IG ΔD/Δd = 1.0 evaluation of the VMAT PSQA results, with a GAI of 95%, is 1.6 ± 0.2%/1.6 ± 0.2 mm, which is just within 2%/2 mm.
This suggests that if 2%/2 mm was used in a standard gamma calculation, the resulting mean GAI would be slightly higher than 95% (in fact, the results of this study show that it is 97.9 ± 1.5%). This result suggests that using the gamma criteria of 2%/2 mm and GAI of 95% is suitable for the cohort of plans. This finding is consistent with the results estimated using the SPC method 29 for the same cohort of patients. Similarly, Fig. A1 suggests that if a center decided to use a GAI of 100%, then the suitable gamma criteria they should be using is 4%/4 mm, assuming a unity dose-to-distance ratio is preferred.
